Andrew Dickinson

Andrew Dickinson joined the Sutter Health Board of Directors in August 2021. Andy serves as Gilead's chief financial officer, responsible for the oversight of the company’s global finance, corporate development, information technology, operations and strategy organizations. He joined Gilead in 2016, and prior to his current role served as head of the company’s corporate development and strategy group. In that role, Andy drove all of Gilead’s licensing, partnership and acquisition transactions and guided investments into new areas.

Prior to his tenure at Gilead, Andy was the global co-head of Healthcare Investment Banking at Lazard. Earlier in his career, he served as General Counsel and Vice President of Corporate Development at Myogen Inc., which was acquired by Gilead in 2006.